Clinical trials
Completed Hyperlipidemias trials in Mexico
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 3 |
| 2006 | 2 |
| 2007 | 2 |
| 2013 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 3 |
| Pfizer | 2 |
| 89bio, Inc. | 1 |
| Amgen | 1 |
| Asociación Científica Latina A.C. | 1 |
| Bayer | 1 |
| Ionis Pharmaceuticals, Inc. | 1 |
| National Heart Institute, Mexico | 1 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 1 |
| Regeneron Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperlipidemias | 14 |
| Diabetes Mellitus | 3 |
| Dyslipidemias | 3 |
| Hypercholesterolemia | 3 |
| Hypertension | 3 |
| Hypertriglyceridemia | 3 |
| Hyperlipoproteinemia Type II | 2 |
| Lipid Metabolism Disorders | 2 |
| Metabolic Diseases | 2 |
| Proteinuria | 2 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.